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774a Wednesday, February 19, 2014of sarcomeres along the myocyte caused marked underestimation of sarcomere
lengthening speed due to superpositioning of different timings for lengthening
between sequentially connected sarcomeres. Then, we found that following
the treatment with ionomycin, neonatal myocytes exhibited spontaneous
sarcomeric oscillations (Cell-SPOC) at partial activation with blockage of
sarcoplasmic reticulum functions, and the waveform properties were indistin-
guishable from those obtained in electric field stimulation. The myosin acti-
vator, omecamtiv mecarbil, markedly enhanced Z-disc displacement during
Cell-SPOC. Finally, we interpreted the present experimental findings in the
framework of our mathematical model of spontaneous sarcomeric oscillations
(Sato, K. et al., Prog Biophys Mol Biol. 2011; Sato, K. et al., Phys. Rev. Lett.
2013). The present experimental system has a broad range of application pos-
sibilities for unveiling single sarcomere dynamics during excitation-contraction
coupling in cardiomyocytes under various settings.
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A mutation in the giant elastic protein titin has recently been linked to arrhyth-
mogenic cardiomyopathy (AC), a disease primarily characterized by fibrofatty
infiltration of the myocardium. Titin is the first sarcomeric protein linked to
AC. In addition to largely unstructured segments, the extensible I-band region
of titin contains ~40 immunoglobulin(Ig)-like domains that are natively folded
as highly stable beta barrels. One of these domains, Ig10, contains a single
Thr/Ile mutation that leads to AC. The first step in determining how this mu-
tation leads to severe cardiac diseasewas to study themutation at the singlemole-
cule level using atomic forcemicroscopy (AFM) and in vitro degradation assays.
With AFM individual proteins are mechanically stretched, and it was found that
the mutation significantly reduces the force needed to unfold Ig10. Although no
difference in refolding rate was found, by comparing the experimental AFM
unfolding forces with computer simulated Ig unfolding, it was found that the
mutation increases Ig10’s unfolding rate fourfold. This effect predicts increased
Ig10 unfolding (i.e. transition into a non-native state) under physiological condi-
tions. It was also found that mutant Ig10 is more prone to protease degradation
due to compromised local structure at the point mutation. This suggests that
accelerated titin turnover in cardiomyocytes instigates the cardiac remodeling
process in patients with titin-linked AC. This is the first time an Ig domain in
titin’s elastic I-band region has been linked to cardiac disease, and this study
proposes a novel disease mechanism contingent on Ig domain unfolding.
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Increased myocardial contractility by beta-adrenergic stimulation requires
precise coordination between cardiac myocyte membrane potential, calcium
handling, and myofilament mechanics. From a myofilament standpoint, more
stoke volume at a given end-diastolic volume ideally would involve both faster
loaded shortening for more ejection coupled with greater shortening-induced
cooperative deactivation to assist in relaxation, which would help assure
adequate filling at higher heart rates. We tested if myofilaments elicit these
characteristics by direct measurement of myocardial sarcomere shortening dur-
ing load clamps before and after PKA treatment, a downstream beta-adrenergic
signaling molecule. Rat skinned ventricular cardiac myocyte preparations
(n = 6) were attached between a force transducer and motor, calcium activated
to elicit ~30% maximal force, and then light-to-moderate load clamps were
induced by a servo-controlled feedback system. Initial sarcomere length was
set at ~2.25 mm and sarcomere shortening was monitored during the load
clamps using an IonOptix SarcLen system at 240 Hz. Interestingly, PKA
seemed to result in the aforementioned ideal changes in sarcomere mechanics.
First, loaded sarcomere shortening velocities were faster following PKA treat-
ment (control = 0.8385 0.198 mm/sec/sarcomere (n= 20) at loads of 0.175
0.06 isometric force (Po); PKA = 1.2155 0.071 mm/sec/sarcomere (n = 31) at
loads of 0.15 5 0.07 Po (p < 0.001) (means 5 SD)). In addition, PKA
appeared to yield greater shortening-induced cooperative deactivation
during load clamps by exhibiting greater curvature of sarcomere length traces,
which was indexed by the rate constant of sarcomere shortening (kshortening),
(Control kshortening = 4.275 1.47; PKA kshortening = 6.93 5 2.48 (p < 0.001)
(means 5 SD)). These findings illustrate the fine tuning of the myofilament
"clock" to help match the resetting of the membrane and calcium clocks after
beta-adrenergic stimulation.3905-Pos Board B633
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Recombinant human cardiac actin mutant E361G, known to cause FDC in
humans, and its WT counterpart were expressed in baculovirus/insect cells.
These actins were used to reconstitute the thin filament of bovine cardiac fibers,
together with bovine cardiac tropomyosin (Tm) and troponin (Tn). Effects of
[Ca2þ], [ATP], [phosphate], and [ADP] on tension and its transients were
studied at 25C. After actin filament reconstitution, tension of WT actin
reconstituted fibers (Ta) reached 0.7550.06 T0 (T0=tension of native fibers),
which was not different from rabbit skeletal actin reconstituted fibers
(Ta=0.7350.07 T0). E361G also generated similar tension after actin reconsti-
tution (Ta=0.7150.12 T0). After Tm and Tn reconstitution, tension at pCa 4.66
(referred to THC) for E361G reached 0.8450.09 T0, which was similar with that
of WT (0.8550.06 T0). In the pCa-tension study, E361G increased the cooper-
ativity (nH=3.950.7) without altering Ca
2þ sensitivity (pCa50=5.7650.03)
compared with those of WT (nH=2.650.3, pCa50=5.7050.03). E361G caused
no relaxation dysfunction in the reconstituted fibers as shown by the unchanged
TLC (tension at pCa 8.0: 0.0850.02 T0) compared toWT (0.0850.01 T0). Tm’s
allosteric effect on the actin-myosin interaction is assessed from the ratio
THC/Ta, which remained similar between E361G (1.2850.10) and WT
(1.1750.08). Five equilibrium constants of the cross-bridge cycle were
deduced using sinusoidal analysis. E361G caused a significant decrease in K2
(cross-bridge detachment: 0.2750.05) compared to that of WT (0.7850.13).
Other equilibrium constants did not change significantly. As a result, E361G
formed significantly more (~20%) force generating cross-bridges than that
of WT, indicating that force/cross-bridge is decreased by ~20% in E361G.
We conclude that increased nH and/or decreased force/cross-bridge may trigger
the signal cascade that eventually results in FDC phenotype.
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Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease
characterized by thickened heart walls, cardiac arrhythmias, myocyte disarray
and interstitial fibrosis. Over 10 mutations in alpha-cardiac actin (ACTC) are
associated with HCM. The ACTC Ala295Ser substitution causes a highly pene-
trant disease with diverse phenotypes. To investigate the in vivo consequences
of the ACTC mutation we generated Drosophila lines with muscle-specific
expression of A295S actin. Our unique models limit genetic diversity and
pathological complexity to help resolve molecular mechanisms of diseases.
For expression in the fly heart we used UAS-Act57BWT and UAS-Act57BA295S
actin transgenes in conjunction with the HandGal4 cardiac-specific driver.
Confocal microscopy confirmed heart-restricted expression of UAS-
Act57BWTGFP and UAS-Act57BA295SGFP and co-polymerization of trans-
genic and endogenous actin. High-speed video microscopy and motion analysis
revealed A295S actin expression significantly reduced diastolic volumes and
increased systolic intervals consistent with elevated contractile properties at
rest and during contraction. For indirect flight muscle (IFM)-specific actin
expression, we used the IFM targeted Act88FWTand Act88FA295S transgenes,
in an IFM actin null background. Muscle mechanics on heterozygous IFM
fibers revealed that the A295S actin mutation increased power, the frequency
of maximum power generation (fmax), and stiffness relative to control fibers.
The higher fmax and stiffness are likely causes of an observed increase in
wing beat frequency (WBF) of Act88FA295Sheterozygous flies. The WBF
increase had a negative impact on flight ability which decreased further as
mutant: wildtype actin ratios were increased. Overall, enhanced contractile
activity of actin HCM cardiac myocytes and IFM fibers is consistent with the
hypercontractile properties frequently associated with HCM mutations.
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Experiments using the in vitro motility assay have shown that the myofilament
Ca2þ-sensitivity is modulated by phosphorylation of troponin I and that the
